Document is current
Any future updates will be listed below
-
Authors
Lécuyer, Lucie
Laouali, Nasser
Dossus, Laure
Shivappa, Nitin
Hébert, James R.
Agudo, Antonio
Tjonneland, Anne
Halkjaer, Jytte
Overvad, Kim
Katzke, Verena A.
Le Cornet, Charlotte
Schulze, Matthias B.
Jannasch, Franziska
Palli, Domenico
Agnoli, Claudia
Tumino, Rosario
Dragna, Luca
Iannuzzo, Gabriella
Jensen, Torill Enget
Brustad, Magritt
Skeie, Guri
Zamora-Ros, Raul
Rodriguez-Barranco, Miguel
Amiano, Pilar
Chirlaque, María-Dolores
Ardanaz, Eva
Almquist, Martin
Sonestedt, Emily
Sandström, Maria
Nilsson, Lena Maria
Weiderpass, Elisabete
Huybrechts, Inge
Rinaldi, Sabina
Boutron-Ruault, Marie-Christine
Truong, Thérèse https://orcid.org/0000-0002-2943-6786
-
Funding
Funding for this research was provided by:
Fondation ARC pour la Recherche sur le Cancer
- License Information
-
More Information
Article History
Received: 28 January 2022
Accepted: 21 April 2022
First Online: 30 May 2022
Declarations
:
: Dr. Marie-Christine Boutron-Ruault declares the following two sponsored conferences outside the present work as: MAYOLI-SPINDLER: 03/07/2020–30/07/2020 Symposium: Pancreatology in practice in 2020 e-JFHOD 2020 Conference « Why do I see more and more pancreatic cancers?» GILEAD 04/12/2020–04/12/2020- e-conference Weight gain and HIV infection in 2020. Dr. James R. Hébert owns controlling interest in Connecting Health Innovations LLC (CHI), a company that has licensed the right to his invention of the dietary inflammatory index (DII<sup>®</sup>) from the University of South Carolina in order to develop computer and smart phone applications for patient counseling and dietary intervention in clinical settings. Dr. Nitin Shivappa is an employee of CHI. The subject matter of this paper will not have any direct bearing on that work, nor has that activity exerted any influence on this project.
: The study was conducted according to the guidelines of the Declaration of Helsinki. Approval for the EPIC study was obtained from the ethical review boards of the International Agency for Research on Cancer (IARC) and all national recruitment institutions. Informed consent was obtained from all EPIC participants.
